Successful mergers don’t just consolidate services. They unify people around a shared mission to serve their patients. If we want to see lasting success in healthcare M&A, it’s time to stop leading with checklists and start leading with people.
Radiotherapy, China's biotech surge and AI's role in drug discovery are notable topics that emerged from conversations on the ground floor.
AI-native tax firm Gelt combines top human tax experts with AI to help physicians and healthcare practices use data-driven tax strategies to lower liabilities, improve profitability, and future-proof their finances.
Health systems preparing for an M&A, or even those not immediately considering one, must prioritize a robust workforce data strategy. This approach is essential for navigating today’s increasingly frequent healthcare consolidations.
Current trends are driven by various strategic and financial considerations from both established pharmaceutical companies and development-stage biotech firms. Understanding the valuation and accounting implications of these transactions are crucial for stakeholders to navigate the complex landscape effectively.
It's a sign of the times: PerkinElmer has acquired Euroimmun, a diagnostics company with a strong market presence in China and other emerging markets.
Nine out of 10 large pharma companies spend more on marketing than they do on R&D. It's a statistic often cited as a sign of industry greed, but it may be the best way to foster real innovation.
Greenway Health blends smart technology with human expertise to elevate revenue cycle.